Pharma

First Opinion Arthur L. Caplan

STAT Plus: How I helped Pfizer think through the ethics of Viagra 25 years ago

Health Jason Mast

STAT Plus: After new cluster, health officials warn mpox could resurge this summer

Pharmalot Ed Silverman

STAT Plus: Supreme Court rules against Amgen in closely watched case over scope of patent claims

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Appellate judges appear skeptical of FDA decisions on abortion pill; FTC widens probe into PBMs

Pharmalot Ed Silverman

STAT Plus: FTC widens probe into pharmacy benefit managers to include group purchasing organizations

Politics John Wilkerson

STAT Plus: Could an upcoming Supreme Court case make the FDA slower?

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FTC suit over Amgen spotlights ‘bundling’ deals with insurers; FDA staff says Pfizer RSV vaccine is effective

Pharmalot Ed Silverman

STAT Plus: FTC move to block the Amgen-Horizon deal highlights concerns over negotiations with insurers

Politics Rachel Cohrs

STAT Plus: AstraZeneca is third member to leave PhRMA in five months

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FTC may sue to block Amgen deal for Horizon; Supreme Court declines Teva appeal on skinny labeling

First Opinion Dinesh S. Thakur and Prashant Reddy Thikkavarapu

STAT Plus: The U.S. needs to pressure India to improve drug safety

First Opinion Antonio Capone Jr.

STAT Plus: A breakthrough drug will require big changes for eye care doctors

Pharmalot Ed Silverman

STAT Plus: U.S. Supreme Court declines bid by Teva to hear ‘skinny labeling’ case with implications for generic drug access

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA OKs new kind of drug to treat hot flashes; Alzheimer’s drug could cost Medicare up to $5 billion a year

First Opinion Scott Brunner

STAT Plus: Compounding pharmacies offer a fix for shortages of essential drugs

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: U.S. Senate committee passes PBM bills; Pfizer CEO predicts pharma will sue over Medicare price negotiations

Pharmalot Ed Silverman

STAT Plus: AbbVie sues a behind-the-scenes company for exploiting its patient assistance program

Politics John Wilkerson

STAT Plus: Senate panel passes a suite of drug pricing bills — but fails to advance one major PBM reform

Pharmalot Ed Silverman

STAT Plus: Wyden decries ‘astonishingly low’ tax rates for pharma companies as he probes business maneuvers

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA panel recommends first OTC birth control pill; Senate hearing on insulin costs satisfies no one

Politics John Wilkerson

STAT Plus: Telework helps FDA compete for scientists. What if it’s no longer an option?

Politics Sarah Owermohle

STAT Plus: Insulin makers, PBMs echo old finger-pointing in Senate hearing

Pharmalot Ed Silverman

STAT Plus: FDA panel votes in favor of the first over-the-counter birth control pill

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Gilead wins lawsuit against HHS over HIV pill patents; most Americans say abortion pill should remain on the market

Pharma Elaine Chen

STAT Plus: In small study, weight loss drug boosts immune cells that help fight cancer

Pharmalot Ed Silverman

STAT Plus: What FDA mandate? Sun Pharma halts shipments from a plant with a troubled history

Pharmalot Ed Silverman

STAT Plus: Gilead defeats federal government in closely watched battle over patents for HIV prevention pills

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Big pharma maps legal strategy against U.S. drug pricing reform; U.S. pharma layoffs continue to climb